XML 50 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2014
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
The following table summarizes stock option activity for the six months ended June 30, 2014:
 
 
 
Number
of shares
 
Weighted-
average
exercise price
 
Weighted-
average
Contractual
Term
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
(in years)
 
 
 
 
Outstanding at December 31, 2013
 
46,591
 
$
46.37
 
8.50
 
$
 
Granted
 
 
 
 
 
 
 
 
 
Exercised
 
 
 
 
 
 
 
 
 
Forfeited
 
 
 
 
 
 
 
 
 
Expired
 
(359)
 
 
4,640.63
 
 
 
 
 
 
Outstanding at June 30, 2014
 
46,232
 
$
10.70
 
8.07
 
$
229,540
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and expected to vest at June 30, 2014
 
37,232
 
$
12.22
 
8.07
 
$
184,630
 
Exercisable at June 30, 2014
 
37,232
 
$
12.22
 
8.07
 
$
184,630
 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
The following table summarizes restricted share activity for the six months ended June 30, 2014:
 
 
 
Number of Shares
 
Weighted
Average
Grant Date
Fair Value
 
Outstanding at December 31, 2013
 
7,034,957
 
$
4.60
 
Granted
 
297,690
 
 
8.14
 
Vested
 
(502,124)
 
 
6.88
 
Forfeited
 
 
 
 
Outstanding at June 30, 2014
 
6,830,523
 
$
4.65
 
Schedule Of Warrants Activity [Table Text Block]
The following table summarizes warrant activity for the six months ended June 30, 2014:
 
 
 
Warrants
 
Weighted-
average
exercise price
 
Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2013
 
5,718,947
 
$
1.34
 
$
14,809,030
 
Issued
 
 
 
 
 
 
 
Exercised
 
(700,230)
 
 
2.29
 
 
 
 
Expired
 
(9,795)
 
 
20.92
 
 
 
 
Outstanding at June 30, 2014
 
5,008,922
 
$
1.17
 
$
41,163,640
 
Schedule Of Share Based Compensation Expense [Text Block]
The following table summarizes stock-based compensation expense information about stock options and restricted stock for the three and six months ended June 30, 2014:
 
 
 
Three months ended
June 30, 2014
 
Six months ended
June 30, 2014
 
Stock-based compensation expense associated with restricted stock
 
$
7,486,336
 
$
11,717,774
 
Stock-based compensation expense associated with option grants
 
 
252,510
 
 
252,510
 
 
 
$
7,738,846
 
$
11,970,284